Lv3
350 积分 2021-04-21 加入
Nivolumab in patients with advanced gastric or gastro-oesophageal junction cancer refractory to, or intolerant of, at least two previous chemotherapy regimens (ONO-4538-12, ATTRACTION-2): a randomised, double-blind, placebo-controlled, phase 3 trial
1天前
已完结
Laparoscopic hyperthermic intraperitoneal chemotherapy (HIPEC) for the treatment of malignant ascites secondary to unresectable peritoneal carcinomatosis from advanced gastric cancer
12天前
已完结
Hypothesis-generating evaluation of multi-armoured oncolytic HSV-1 (VG161) in intrahepatic cholangiocarcinoma: pooled insights from multicentre studies
17天前
已完结
HBsAg-tagged tumour vaccine system eliminates solid tumours through virus-specific memory T cells
1个月前
已完结
Plasma caffeine levels are not causally linked to the risk of lung cancer
1个月前
已完结
Assessing the genetic estimates of the association between plasma caffeine and cancer risk through Mendelian randomization
1个月前
已完结
In vivo chimeric antigen receptor (CAR)-T cell therapy
1个月前
已完结
Effectiveness of intraperitoneal or intrapleural administration of triamcinolone acetonide for the control of malignant ascites and pleural effusion (Kansai Clinical Oncology Group-G1102 study)
2个月前
已关闭
Intravenous aflibercept for treatment of recurrent symptomatic malignant ascites in patients with advanced ovarian cancer: a phase 2, randomised, double-blind, placebo-controlled study
2个月前
已完结
Oncolytic viruses as anticancer agents: clinical progress and remaining challenges
2个月前
已完结
皖公网安备34019202002308
